The neuromodulation system to treat obstructive sleep apnea is the most common, affects millions of people and can cause high blood pressure, heart disease and stroke.

Companies are now marketing an implant that provides stimulation to open important muscles of the airways during sleep. Controlled by a remote patch or placed on the patient, the technology acts as a pacemaker, which helps to synchronize the air intake with the action of the tongue through a breathing sensor and a stimulation cable driven by a small battery.

These neuromodulation systems have had positive results in clinical trials and this technology is expected to provide a better night’s sleep to more patients and spouses, thus promoting healthier communities.

These and other innovations are now possible in Pharmamedic.